Literature DB >> 15061726

Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques.

R Renne1, D Dittmer, D Kedes, K Schmidt, R C Desrosiers, P A Luciw, D Ganem.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a gamma-herpesvirus associated with Kaposi's sarcoma (KS) and two lymphoproliferative diseases, primary effusion lymphoma (PEL) and multicentric Castleman's disease. Studies on the biology and pathogenesis of KSHV have been limited by lack of efficient cell culture systems and lack of a suitable animal model for KS. Here we report on the experimental inoculation of SIV-positive and SIV-negative rhesus macaques with KSHV-infected PEL cells or KSHV preparations derived from PEL cells. Low levels of viral DNA could be detected in cultivated peripheral blood mononuclear cell of all animals, as well as in the bone marrow of one monkey that died from SAIDS. However, we were not able to detect KSHV-specific antibodies or transcripts, nor did we observe any symptoms clearly related to KSHV infection (e.g. KS or lympho-proliferative disease). Hence, although KSHV replicates in rhesus macaques at very low levels, this non-human primate host is unlikely to provide a useful animal model for disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061726     DOI: 10.1046/j.1600-0684.2003.00043.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  17 in total

Review 1.  Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Authors:  Hye-Ra Lee; Stacy Lee; Preet M Chaudhary; Parkash Gill; Jae U Jung
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

3.  KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.

Authors:  Christopher H Parsons; Laura A Adang; Jon Overdevest; Christine M O'Connor; J Robert Taylor; David Camerini; Dean H Kedes
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

4.  Rhesus Macaque Rhadinovirus Encodes a Viral Interferon Regulatory Factor To Disrupt Promyelocytic Leukemia Nuclear Bodies and Antagonize Type I Interferon Signaling.

Authors:  Laura K Springgay; Kristin Fitzpatrick; Byung Park; Ryan D Estep; Scott W Wong
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.

Authors:  Alexander S Hahn; Anna K Großkopf; Doris Jungnickl; Brigitte Scholz; Armin Ensser
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

6.  Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development.

Authors:  Ryan D Estep; Michael F Powers; Bonnie K Yen; He Li; Scott W Wong
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

7.  Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Lin-Xu Wang; Guobin Kang; Pankaj Kumar; Wuxun Lu; Yue Li; You Zhou; Qingsheng Li; Charles Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

8.  Increased tumorigenicity of cells carrying recombinant human herpesvirus 8.

Authors:  N Cloutier; O van Eyll; M-E Janelle; S Lefort; S-J Gao; L Flamand
Journal:  Arch Virol       Date:  2007-10-18       Impact factor: 2.574

9.  Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus.

Authors:  Kwun Wah Wen; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

Review 10.  Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.

Authors:  Susan V Westmoreland; Keith G Mansfield
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.